Medexus Schedules Second Fiscal Quarter 2027 Conference Call
Newsfile Corp•03/11/2026•17:26 ET
0
Key Highlights
- ➤Medexus schedules Q2 fiscal 2027 results conference call for November 12, 2026
- ➤Financial statements and MD&A expected after markets close November 11, 2026
- ➤Medexus will discuss results for quarter ended September 30, 2026
Expert Statements
Ken d'Entremont, CEO of Medexus Pharmaceuticals
“Medexus Pharmaceuticals”
Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - November 3, 2026) - Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) plans to host a conference call at 8:00 am Eastern Time on Thursday, November 12, 2026, to discuss Medexus's results for its second fiscal quarter ended September 30, 2026. Medexus expects to file its financial statements and MD&A after markets close on November 11, 2026.
To participate in the call, please dial the following numbers:
Get started
Create a free account to read the full story.